ArthroCare v. S&N: Enjoined Arthroscopy Sales Totaled $10 Mil. In 2003
This article was originally published in The Gray Sheet
Executive Summary
An injunction against sales of Smith & Nephew arthroscopy devices found to infringe 16 ArthroCare patents will not be delayed by S&N's appeal under an April 27 court ruling, ArthroCare says
You may also be interested in...
ArthroCare And Smith & Nephew Resolve Litigation Via Distribution Deal
ArthroCare will manufacture bipolar and monopolar arthroscopy products that Smith & Nephew Endoscopy will sell worldwide as part of an agreement to end litigation between the two companies
ArthroCare And Smith & Nephew Resolve Litigation Via Distribution Deal
ArthroCare will manufacture bipolar and monopolar arthroscopy products that Smith & Nephew Endoscopy will sell worldwide as part of an agreement to end litigation between the two companies
Arthrocare Coblation patent decision
Smith & Nephew's request to delay a sales injunction of its bipolar arthroscopy wands - Saphyre, Control RF and ElectroBlade - is denied by the U.S. Federal Circuit Court of Appeals, Arthrocare announces in a June 10 call. The U.S. District Court in Delaware found that S&N infringed 16 patents relating to Arthrocare's Coblation arthroscopy technology, requiring S&N to remove its wands from the market by July 27. S&N still plans to appeal the initial April injunction (1"The Gray Sheet" May 3, 2004, p. 16). Arthrocare CEO Michael Baker noted the appeal could take "a year or more." In 2003, bipolar arthroscopy devices generated $10 mil. in sales for Smith & Nephew...